# Dantari

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dantari

- Industry: Biotechnology
- Headquarters: Thousand Oaks, US
- Website: www.dantari.com
- Total disclosed funding: $47M
- Latest round: Series A (Dec 8, 2022)
- Investors on record: 4

## About

Based in the US, Dantari, Inc. operates as a technology provider, delivering innovative solutions that enhance operational efficiency and user engagement across various industries.Dantari, Inc. was founded in 2018 in Thousand Oaks, US and focuses on providing advanced technological solutions. The company has successfully completed a total of 3 deals, with its most recent deal occurring on December 8, 2022. In this round, Dantari raised USD 47.00 mn in Series A funding led by Westlake Village BioPartners, with participation from Alexandria Venture Investments, CalTech, and Corner Ventures. Richard Markus serves as the CEO of the company.Dantari specializes in providing a range of innovative solutions tailored to meet the needs of its diverse client base. Its core product offerings include advanced technological solutions designed to streamline operational processes and enhance user engagement across various sectors. The primary end-use cases involve optimizing workflow efficiencies and improving customer interaction experiences, particularly beneficial in industries such as e-commerce and digital marketing. The company targets geographical markets in North America, Europe, and parts of Asia, serving both B2B and B2C clients across multiple industries.Dantari generates revenue through a structured transaction model that includes subscription services, direct sales, and partnerships with key industry players. Clients engage with the company primarily via subscription plans that offer tiered access to its flagship products, catering to varying levels of user needs. This multifaceted approach allows Dantari to maintain a sustainable business model while effectively serving individual users and larger organizations.In December 2022, Dantari, Inc. raised USD 47.00 mn in Series A funding, which will be utilized to support the development of new products that enhance operational efficiencies. The company is also planning to expand into new markets, specifically targeting Europe and parts of Asia by the end of 2023. This funding round, led by Westlake Village BioPartners, alongside other investors, will aid in these efforts.

## Funding rounds

- Series A, Dec 8, 2022, $47M — Alexandria Venture Investments, CalTech, Westlake Village BioPartners, Corner Ventures
- Seed, Apr 26, 2021 — Corner Ventures

## Investors

- Corner Ventures (https://capitalatlas.ai/funds/corner-ventures) — Seed, Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- CalTech (https://capitalatlas.ai/funds/caltech) — Series A
- Westlake Village BioPartners (https://capitalatlas.ai/funds/westlake-village-biopartners) — Series A